Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study

Publication date: November 2020Source: The Lancet HIV, Volume 7, Issue 11Author(s): Max Lataillade, Jacob P Lalezari, Michael Kozal, Judith A Aberg, Gilles Pialoux, Pedro Cahn, Melanie Thompson, Jean-Michel Molina, Santiago Moreno, Beatriz Grinsztejn, Ricardo S Diaz, Antonella Castagna, Princy N Kumar, Gulam H Latiff, Edwin De Jesus, Marcia Wang, Shiven Chabria, Margaret Gartland, Amy Pierce, Peter Ackerman
Source: The Lancet HIV - Category: Infectious Diseases Source Type: research